Back
Theravance Biopharma Stock Predictions
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
47
TBPH
Theravance Biopharma
Last Price:
8.23
Seasonality Move:
11.3%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Theravance Biopharma Stock Forecast
- Over the next 52 weeks, Theravance Biopharma has on average historically fallen by 1.1% based on the past 10 years of stock performance.
- Theravance Biopharma has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Theravance Biopharma Stock Undervalued?
The current Theravance Biopharma [TBPH] share price is $8.22. The Score for TBPH is 47, which is 6% below its historic median score of 50, and infers higher risk than normal. - TBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Theravance Biopharma Stock Go Up Next Year?
- Over the next 52 weeks, Theravance Biopharma has on average historically fallen by 1.1% based on the past 10 years of stock performance.
Theravance Biopharma Stock Rating
Sell
47
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma overpriced?
- Theravance Biopharma has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Theravance Biopharma Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Cayman Islands
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
theravance.com
52-Week Data
52-Week High:
11.71
52-Week Low:
7.44
Prediction Charts
Market Cap:
402.14M
Price in USD:
8.22
Volume:
80.09K
Beta:
0.72
Technical Analysis
SMA50:
8.24
SMA100:
8.58
SMA200:
8.83
52-Wk Change:
-16.55%
Stock Predictions
-
Is Theravance Biopharma stock public?
Yes, Theravance Biopharma is a publicly traded company. -
What is the Theravance Biopharma stock quote today?
The Theravance Biopharma stock price is 8.22 USD today. -
How to buy Theravance Biopharma stock online?
You can buy Theravance Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-15 | 8.25 | 8.60 | 8.75 | 8.25 |
| Oct-16 | 8.63 | 8.70 | 8.81 | 8.56 |
| Oct-18 | 8.65 | 8.80 | 8.82 | 8.56 |
| Oct-21 | 8.78 | 8.66 | 8.78 | 8.62 |
| Oct-22 | 8.62 | 8.80 | 8.82 | 8.54 |
| Oct-23 | 8.67 | 8.63 | 8.86 | 8.45 |
| Oct-24 | 8.58 | 8.64 | 8.68 | 8.56 |
| Oct-25 | 8.64 | 8.55 | 8.70 | 8.52 |
| Oct-28 | 8.47 | 8.77 | 8.93 | 8.47 |
| Oct-29 | 8.73 | 8.65 | 8.76 | 8.56 |
| Oct-30 | 8.61 | 8.47 | 8.65 | 8.47 |
| Oct-31 | 8.49 | 8.24 | 8.58 | 8.24 |
| Nov-1 | 8.46 | 8.28 | 8.46 | 8.22 |
| Nov-4 | 8.24 | 8.22 | 8.31 | 8.21 |
Theravance Biopharma Earnings
Theravance Biopharma Earnings Report: Per Share Theravance Biopharma Earnings Q1 Q2 Q3 and Q4 last year and next year.
Theravance Biopharma Forecast Revenue Growth
Theravance Biopharma Stock Analysis: Historical quarterly revenues per share for Theravance Biopharma and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $1.09 per share.
* Theravance Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.